Thermo Fisher CEO Says AI Will Drive More Pharma Spending — Sees 7% Organic Growth By 2028
In an interview with CNBC on Tuesday, Marc Casper said AI is helping drugmakers identify ineffective medicines quicker while also shortening the time to market for promising therapies. Casper said Thermo Fisher expects organic growth of about 4% in the second half of 2026. The CEO said drugmakers could spend more to test promising medicines … Read more